Alzamend Neuroâ˘, Inc. (âAlzamendâ˘â) is a biotechnology company dedicated to the research, development and commercialization of pharmaceuticals for the treatment and cure of Alzheimerâs disease. Alzamend Neuro⢠is currently working to transition two therapeutics targeting Alzheimerâs disease (âADâ) from the research and preclinical stage at the University of South Florida into the clinical stage and towards full commercialization. Alzamend Neuro⢠has licensed both a patented mutant-peptide immunotherapeutic (CAO22W) for use as a treatment or vaccine and a lithium based ionic cocrystal therapy (LiProSalâ˘) that may greatly reduce or eliminate the symptoms of agitation and other endpoints for mild to moderate stage patients diagnosed with AD. There are no profound treatments today for Alzheimerâs disease. With CAO22W and LiProSalâ˘, the Company believes that Alzamend⢠can change that.
No articles found.
OpGen, Inc. is a precision medicine company harnessing the power of molecular diag...
OpGen, Inc. is a precision medicine company har...
SINTX Technologies is a commercial biomaterial company focused on using its silico...
SINTX Technologies is a commercial biomaterial ...
CONMED is a medical technology company that provides surgical devices and equipmen...
CONMED is a medical technology company that pro...
Eniware, LLC provides portable, power-independent medical instrument sterilization...
Eniware, LLC provides portable, power-independe...
NanoString Technologies is a leading provider of life science tools for translatio...
NanoString Technologies is a leading provider o...
Over a century ago in Melbourne, Australia, we made a promise to save lives and pr...
Over a century ago in Melbourne, Australia, we ...
DIVINIA Water produces bottled water with a proprietary purification technique tha...
DIVINIA Water produces bottled water with a pro...
Veteran-owned and woman-founded, Natural Selection was established 2017 outside of...
Veteran-owned and woman-founded, Natural Select...
Our current primary focus verticals are the US human and pet wellness CBD market a...
Our current primary focus verticals are the US ...
We are an innovative clinical-stage biopharmaceutical company primarily focused on...
We are an innovative clinical-stage biopharmace...
Join the National Investor Network and get the latest information with your interests in mind.